Treatments for gestational trophoblastic disease

References

• WHO. Gestational trophoblastic diseases, Technical Report series 692. WHO, Geneva, Switzerland, 7–81 (1983).
   Google Scholar
• Kohorn EI. The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: description and critical assessment. Int. J. Gynecol. Cancer11, 73–77 (2001).
   PubMed Web of Science ®Google Scholar
• Garner EI, Lipson E, Bernstein MR, Goldstein DP, Berkowitz RS. Subsequent pregnancy experience in patients with molar pregnancy and gestational trophoblastic tumor. J. Reprod. Med.47, 380–386 (2002).
   PubMedGoogle Scholar
• Fisher RA, Hodges MD. Genomic imprinting in gestational trophoblastic disease – a review. Placenta24(Suppl. A), S111–S118 (2003).
   PubMed Web of Science ®Google Scholar
• Muller CY, Cole LA. The quagmire of hCG and hCG testing in gynecologic oncology. Gynecol. Oncol.112, 663–672 (2009).
   PubMed Web of Science ®Google Scholar
• Sturgeon CM, Berger P, Bidart JM et al. Differences in recognition of the 1st WHO international reference reagents for hCG-related isoforms by diagnostic immunoassays for human chorionic gonadotropin. Clin. Chem.55, 1484–1491 (2009).
   PubMed Web of Science ®Google Scholar
• Mitchell H, Seckl MJ. Discrepancies between commercially available immunoassays in the detection of tumour-derived hCG. Mol. Cell. Endocrinol.260–262, 310–313 (2007).
   PubMedGoogle Scholar
• Cole LA. New discoveries on the biology and detection of human chorionic gonadotropin. Reprod. Biol. Endocrinol.7, 8 (2009).
   PubMed Web of Science ®Google Scholar
• Bagshawe KD. Clinical applications of hCG. Adv. Exp. Med. Biol.176, 313–324 (1984).
   PubMedGoogle Scholar
• Vaitukaitis JL. Human chorionic gonadotrophin-a hormone secreted for many reasons. N. Engl. J. Med.301, 324–326 (1979).
   PubMed Web of Science ®Google Scholar
• Fisher RA, Savage PM, MacDermott C et al. The impact of molecular genetic diagnosis on the management of women with hCG-producing malignancies. Gynecol. Oncol.107, 413–419 (2007).
   PubMed Web of Science ®Google Scholar
• Berkowitz RS, Goldstein DP. Clinical practice. Molar pregnancy. N. Engl. J. Med.360, 1639–1645 (2009).
   PubMed Web of Science ®Google Scholar
• Fowler DJ, Lindsay I, Seckl MJ, Sebire NJ. Routine pre-evacuation ultrasound diagnosis of hydatidiform mole: experience of more than 1000 cases from a regional referral center. Ultrasound Obstet. Gynecol.27, 56–60 (2006).
   PubMed Web of Science ®Google Scholar
• Seckl MJ, Fisher RA, Salerno GA et al. Choriocarcinoma and partial hydatidiform moles. Lancet356, 36–39 (2000).
   PubMed Web of Science ®Google Scholar
• Kajii T, Ohama K. Androgenetic origin of hydatidiform mole. Nature268, 633–634 (1977).
   PubMed Web of Science ®Google Scholar
• Lawler SD, Povey S, Fisher RA, Pickthall VG. Genetic studies on hydatidiform moles II: the origin of complete moles. Ann. Hum. Genet.46, 209–222 (1982).
   PubMedGoogle Scholar
• Fisher RA, Newlands ES. Gestational trophoblastic disease: molecular and genetic studies. J. Reprod. Med.43, 81–97 (1998).
   PubMedGoogle Scholar
• Fisher RA, Povey S, Jeffreys AJ et al. Frequency of heterozygous complete hydatidiform moles, estimated by locus-specific minisatellite and Y chromosome-specific probes. Hum. Genet.82, 259–263 (1989).
   PubMedGoogle Scholar
• Sebire NJ, Seckl MJ. Gestational trophoblastic disease: current management of hydatidiform mole. Br. Med. J.337, a1193 (2008).
   Google Scholar
• Fradken JE, Eastman RC, Lesniak MA, Roth J. Specificity spillover at the hormone receptor-exploring its role in human disease. N. Engl. J. Med.320, 640–645 (1989).
   PubMedGoogle Scholar
• Seckl MJ, Gillmore R, Foskett M et al. Routine terminations of pregnancy – should we screen for gestational trophoblastic neoplasia? Lancet364, 705–707 (2004).
   PubMedGoogle Scholar
• Sebire NJ, Foskett M, Paradinas FJ et al. Outcome of twin pregnancies with complete hydatidiform mole and healthy co-twin. Lancet359, 2165–2166 (2002).
   PubMed Web of Science ®Google Scholar
• McGrath IT, Golding PR, Bagshawe KD. Medical presentations of choriocarcinoma. Br. Med. J.2, 633–637 (1971).
   PubMedGoogle Scholar
• Tidy JH, Rustin GJS, Newlands ES et al. Presentation and management of choriocarcinoma after nonmolar pregnancy. Br. J. Obstet. Gynaecol.102, 715–719 (1995).
   PubMedGoogle Scholar
• Johnson EJ, Crofton PM, O’Neill JM et al. Infantile choriocarcinoma treated with chemotherapy alone. Med. Pediatr. Oncol.41, 550–557 (2003).
   PubMedGoogle Scholar
• Blohm ME, Gobel U. Unexplained anaemia and failure to thrive as initial symptoms of infantile choriocarcinoma: a review. Eur. J. Pediatr.163, 1–6 (2004).
   PubMedGoogle Scholar
• Sebire NJ, Lindsay I, Fisher RA, Seckl MJ. Intraplacental choriocarcinoma: experience from a tertiary referral center and relationship with infantile choriocarcinoma. Fetal Pediatr. Pathol.24, 21–29 (2005).
   PubMed Web of Science ®Google Scholar
• Shih IM, Kurman RJ. The pathology of intermediate trophoblastic tumors and tumor-like lesions. Int. J. Gynecol. Pathol.20, 31–47 (2001).
   PubMed Web of Science ®Google Scholar
• Palmieri C, Fisher RA, Sebire NJ et al. Placental site trophoblastic tumour arising from a partial hydatidiform mole. Lancet366, 688 (2005).
   PubMedGoogle Scholar
• Schmid P, Nagai Y, Agarwal R et al. Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study. Lancet374, 48–55 (2009).
   PubMed Web of Science ®Google Scholar
• Harvey RA, Pursglove HD, Schmid P et al. Human chorionic gonadotropin free β-subunit measurement as a marker of placental site trophoblastic tumors. J. Reprod. Med.53, 643–648 (2008).
   PubMedGoogle Scholar
• Fisher RA, Soteriou BA, Meredith L, Paradinas FJ, Newlands ES. Previous hydatidiform mole identified as the causative pregnancy of choriocarcinoma following birth of normal twins. Int. J. Gynecol. Cancer5, 64–70 (1995).
   PubMedGoogle Scholar
• Papadopoulos AJ, Foskett M, Seckl MJ et al. Twenty-five years’ clinical experience of placental site trophoblastic tumors. J. Reprod. Med.47, 460–464 (2002).
   PubMed Web of Science ®Google Scholar
• Young RH, Scully RE. Placental-site trophoblastic tumor: current status. Clin. Obstet. Gynecol.27, 248–258 (1984).
   PubMedGoogle Scholar
• Eckstein RP, Paradinas FJ, Bagshawe KD. Placental site trophoblastic tumour (trophoblastic pseudotumour): a study of four cases requiring hysterectomy including one fatal case. Histopathology6, 211–226 (1982).
   PubMedGoogle Scholar
• Hui P, Martel M, Parkash V. Gestational trophoblastic diseases: recent advances in histopathologic diagnosis and related genetic aspects. Adv. Anat. Pathol.12, 116–125 (2005).
   PubMed Web of Science ®Google Scholar
• Shih IM, Kurman RJ. Epithelioid trophoblastic tumor: a neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma. Am. J. Surg. Pathol.22, 1393–1403 (1998).
   PubMed Web of Science ®Google Scholar
• Coulson LE, Kong CS, Zaloudek C. Epithelioid trophoblastic tumor of the uterus in a postmenopausal woman: a case report and review of the literature. Am. J. Surg. Pathol.24, 1558–1562 (2000).
   PubMed Web of Science ®Google Scholar
• Tidy JA, Gillespie AM, Bright N et al. Gestational trophoblastic disease: a study of mode of evacuation and subsequent need for treatment with chemotherapy. Gynecol. Oncol.78, 309–312 (2000).
   PubMedGoogle Scholar
• Savage P, Seckl MJ. The role of repeat uterine evacuation in trophoblast disease. Gynecol. Oncol.99, 251–252; author reply 252–253 (2005).
   PubMedGoogle Scholar
• Pfeffer PE, Sebire N, Lindsay I et al. Fertility-sparing partial hysterectomy for placental-site trophoblastic tumour. Lancet Oncol.8, 744–746 (2007).
   PubMed Web of Science ®Google Scholar
• McNeish IA, Strickland S, Holden L et al. Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000. J. Clin. Oncol.20, 1838–1844 (2002).
   PubMed Web of Science ®Google Scholar
• Bower M, Newlands ES, Holden L et al. EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients. J. Clin. Oncol.15, 2636–2643 (1997).
   PubMed Web of Science ®Google Scholar
• Woolas RP, Bower M, Newlands ES et al. Influence of chemotherapy for gestational trophoblastic disease on subsequent pregnancy outcome. Br. J. Obstet. Gynaecol.105, 1032–1035 (1998).
   PubMedGoogle Scholar
• Rustin GJS, Newlands ES, Lutz J-M et al. Combination but not single agent methotrexate chemotherapy for gestational trophoblastic tumours (GTT) increases the incidence of second tumours. J. Clin. Oncol.14, 2769–2773 (1996).
   PubMed Web of Science ®Google Scholar
• Newlands ES, Holden L, Seckl MJ et al. Management of brain metastases in patients with high-risk gestational trophoblastic tumors. J. Reprod. Med.47, 465–471 (2002).
   PubMed Web of Science ®Google Scholar
• Athanassiou A, Begent RHJ, Newlands ES et al. Central nervous system metastases of choriocarcinoma: 23 years’ experience at Charing Cross Hospital. Cancer52, 1728–1735 (1983).
   PubMed Web of Science ®Google Scholar
• Rustin GJS, Newlands ES, Begent RHJ, Dent J, Bagshawe KD. Weekly alternating chemotherapy (EMA/CO) for treatement of central nervous systems of choriocarcinoma. J. Clin. Oncol.7, 900–903 (1989).
   PubMed Web of Science ®Google Scholar
• Gillespie AM, Siddiqui N, Coleman RE, Hancock BW. Gestational trophoblastic disease: does central nervous system chemoprophylaxis have a role? Br. J. Cancer79, 1270–1272 (1999).
   PubMed Web of Science ®Google Scholar
• Osborne R, Covens A, Mirchandani D, Gerulath A. Successful salvage of relapsed high-risk gestational trophoblastic neoplasia patients using a novel paclitaxel-containing doublet. J. Reprod. Med.49, 655–661 (2004).
   PubMed Web of Science ®Google Scholar
• Wang J, Short D, Sebire NJ et al. Salvage chemotherapy of relapsed or high-risk gestational trophoblastic neoplasia (GTN) with paclitaxel/cisplatin alternating with paclitaxel/etoposide (TP/TE). Ann. Oncol.19, 1578–1583 (2008).
   PubMed Web of Science ®Google Scholar
• Stone M, Dent J, Kardana A, Bagshawe KD. Relationship of oral contraception to development of trophoblastic tumour after evacuation of a hydatidiform mole. Br. J. Obstet. Gynaecol.83, 913–916 (1976).
   PubMedGoogle Scholar
• Curry SL, Schlaerth JB, Kohorn EI et al. Hormonal contraception and trophoblastic sequelae after hydatidiform mole (a Gynecologic Oncology Group Study). Am. J. Obstet. Gynecol.160, 805–809; discussion 809–811 (1989).
   PubMed Web of Science ®Google Scholar
• Sebire NJ, Fisher RA, Foskett M et al. Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy. BJOG110, 22–26 (2003).
   PubMed Web of Science ®Google Scholar
• Bower M, Rustin GJ, Newlands ES et al. Chemotherapy for gestational trophoblastic tumours hastens menopause by 3 years. Eur. J. Cancer34, 1204–1207 (1998).
   PubMed Web of Science ®Google Scholar
• Hassadia A, Gillespie A, Tidy J et al. Placental site trophoblastic tumour: clinical features and management. Gynecol. Oncol.99, 603–607 (2005).
   PubMed Web of Science ®Google Scholar
• Newlands ES, Bower M, Fisher RA, Paradinas FJ. Management of placental site trophoblastic tumors. J. Reprod. Med.43, 53–59 (1998).
   PubMed Web of Science ®Google Scholar
• Powles T, Savage P, Short D et al. Residual lung lesions after completion of chemotherapy for gestational trophoblastic neoplasia: should we operate? Br. J. Cancer94, 51–54 (2006).
   PubMedGoogle Scholar
• Newlands ES, Paradinas FJ, Fisher RA. Recent advances in gestational trophoblastic disease. Hematol. Oncol. Clin. North Am.13, 225–244 (1998).
   Google Scholar
• Paradinas FJ. The diagnosis and prognosis of molar pregnancy. The experience of the National Referral Centre in London. Int. J. Gynaecol. Obstet.60, S57–S64 (1998).
   Google Scholar
• Rotmensch S, Cole LA. False diagnosis and needless therapy of presumed malignant disease in women with false positive hCG concentrations. Lancet355, 712–715 (2000).
   PubMed Web of Science ®Google Scholar
• Seckl MJ, Fisher RA, Salerno GA et al. Choriocarcinoma and partial hydatidiform moles. Lancet356, 36–39 (2000).
   PubMed Web of Science ®Google Scholar
• Wang J, Short D, Sebire NJ et al. Salvage chemotherapy of relapsed or high-risk gestational trophoblastic neoplasia with paclitaxel/cisplatin alternating with paclitaxel/etoposide (TP/TE). Ann. Oncol.19, 1578–1583 (2008).
   PubMed Web of Science ®Google Scholar